Yunfeng Zhao Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

10/2015	Silencing Angiopoietin-Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide-Induced Acute Lung Injury Via Regulating SIRT1 /NF-kB Pathway.
4/2006	Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunfeng Zhao Research Topics

Disease

46	Neoplasms (Cancer) 01/2021 - 09/2002
17	Carcinogenesis 01/2019 - 01/2003
10	Body Weight (Weight, Body) 03/2022 - 10/2005
7	Acute Lung Injury 01/2022 - 01/2011
6	Inflammation (Inflammations) 12/2021 - 01/2009
6	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2018
5	Pulmonary Edema 01/2022 - 10/2015
5	Melanoma (Melanoma, Malignant) 01/2020 - 05/2008
4	Lung Neoplasms (Lung Cancer) 12/2021 - 06/2017
4	Skin Neoplasms (Skin Cancer) 01/2018 - 01/2011
4	Breast Neoplasms (Breast Cancer) 06/2015 - 04/2006
3	Pulmonary Embolism 01/2022 - 06/2017
3	Lung Injury 01/2022 - 02/2016
3	Hypertension (High Blood Pressure) 01/2022 - 05/2018
3	Hypoxia (Hypoxemia) 10/2019 - 11/2017
2	Mushroom Poisoning 05/2022 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 05/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2017
2	Cholangiocarcinoma 01/2021 - 01/2019
2	Papillary Thyroid Cancer 02/2020 - 11/2018
2	Adenocarcinoma of Lung 06/2019 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2010
2	Osteoporosis 09/2015 - 04/2006
2	Ovarian Neoplasms (Ovarian Cancer) 11/2014 - 12/2006
1	Wounds and Injuries (Trauma) 05/2022
1	Human Influenza (Influenza) 01/2022
1	Carotid Artery Diseases 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
10	EnzymesIBA 04/2022 - 06/2004
9	AntioxidantsIBA 04/2022 - 06/2004
8	Uncoupling Protein 2IBA 01/2020 - 01/2013
7	CarcinogensIBA 01/2015 - 01/2009
6	Biological ProductsIBA 05/2022 - 01/2014
6	Superoxide DismutaseIBA 04/2014 - 01/2003
5	LipopolysaccharidesIBA 01/2022 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 09/2011
5	AntibodiesIBA 09/2015 - 01/2002
5	Pharmaceutical PreparationsIBA 05/2014 - 12/2006
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2016 - 01/2003
4	Pyruvate KinaseIBA 01/2015 - 09/2011
3	DioxinsIBA 01/2021 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2005
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 07/2014
3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2019 - 10/2005
3	NF-kappa B (NF-kB)IBA 10/2015 - 10/2005
3	Monoclonal AntibodiesIBA 06/2015 - 09/2002
3	shikoninIBA 01/2015 - 01/2014
3	ProtandimIBA 01/2011 - 01/2009
2	tyramine-deoxysorbitolIBA 03/2022 - 03/2022
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 12/2021 - 02/2020
2	Halogenated Diphenyl EthersIBA 01/2021 - 10/2018
2	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 01/2018
2	AcidsIBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 02/2020 - 05/2018
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	genipinIBA 01/2020 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 08/2012
2	withaferin AIBA 10/2019 - 11/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 04/2006
2	Blood Glucose (Blood Sugar)IBA 07/2019 - 07/2018
2	Okadaic AcidIBA 06/2019 - 01/2014
2	CeramidesIBA 01/2019 - 11/2014
2	RNA Precursors (Precursor, mRNA)IBA 01/2019 - 11/2014
2	Mutant Proteins (Protein, Mutant)IBA 01/2019 - 11/2014
2	ORALIT (ORS)IBA 11/2018 - 05/2018
2	LipidsIBA 01/2018 - 10/2017
2	Activating Transcription Factor 3IBA 12/2017 - 10/2017
2	AnionsIBA 11/2017 - 01/2017
2	LigandsIBA 06/2017 - 01/2011
2	CytokinesIBA 02/2016 - 09/2015
2	Small Interfering RNA (siRNA)IBA 02/2016 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 04/2006
2	Phosphotransferases (Kinase)IBA 06/2015 - 01/2014
2	Mitochondrial Uncoupling ProteinsIBA 06/2015 - 01/2011
2	Free RadicalsIBA 06/2015 - 05/2008
2	Protein Isoforms (Isoforms)IBA 01/2015 - 09/2011
2	Tamoxifen FDA LinkGeneric 04/2014 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011 - 06/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2010 - 04/2006
2	Peptides (Polypeptides)IBA 02/2007 - 09/2002
2	CarbohydratesIBA 02/2007 - 09/2002
2	Proteasome InhibitorsIBA 12/2006 - 10/2005
2	Acetates (Acetic Acid Esters)FDA Link 08/2006 - 05/2005
1	Dextrans (Dextran)FDA Link 05/2022
1	AmanitinsIBA 05/2022
1	bis(4-hydroxyphenyl)sulfoneIBA 03/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	prednylidene (Pred)IBA 01/2022
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022
1	Dabigatran FDA Link 01/2022

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2005
3	Immunotherapy 01/2021 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2006
3	Chemoprevention 01/2015 - 01/2009
2	Radiotherapy 01/2021 - 10/2005